HB0129 - Controlled Substance Act-amendments.
2001 |
State of Wyoming |
01LSO-0354.E1 ENGROSSED |
HOUSE BILL NO. HB0129
Controlled Substance Act-amendments.
Sponsored by: Representative(s) Luthi and Rose and
Senator(s) Job
A BILL
for
1 AN ACT relating to the
Wyoming Controlled Substances Act;
2
adding drugs to the schedule of drugs as specified;
3
repealing a drug from the schedule of drugs; and providing
4
for an effective date.
5
6 Be It Enacted by the Legislature of the State of Wyoming:
7
8 Section
1. W.S. 35-7-1014(e) by creating a new
9
paragraph (iii), 35-7-1018(c) by creating new paragraphs
10 (xiii) and (xiv), (g) by creating
new paragraphs (xxvi)
11 through (xxviii) and by creating a
new subsection (h) and
12 35-7-1020(c) by creating a new
paragraph (xlix), (e) by
13 creating new paragraphs (xi) and
(xii) and (f) by creating
14 a new paragraph (ii) are amended to
read:
15
16 35-7-1014. Substances included in Schedule I.
Page 1
1
2 (e) Depressants.-Unless
specifically excepted or
3
unless listed in another schedule, any material compound,
4
mixture or preparation which contains any quantity of the
5
following substances having a depressant effect on the
6
central nervous system, including its salts, isomers, and
7
salts of isomers whenever the existence of such salts,
8
isomers and salts of isomers is possible within the
9
specific chemical designation:
10
11 (iii) Gamma-hydroxybutyric (some other names
12 include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-
13 hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate).
14
15 35-7-1018. Substances included in Schedule III.
16
17 (c) Depressants. -Unless
specifically excepted or
18 listed in another schedule, any
material, compound, mixture
19 or preparation which contains any
quantity of the following
20 substances having a depressant
effect on the central
21 nervous system:
22
Page 2
1 (xiii) Ketamine, its
salts, isomers and salts of
2 isomers (some other names for ketamine
include (±)-2-(2-
3 chlorophenyl)-2-(methylamino)-cyclohexanone);
4
5 (xiv) Any drug product
containing gamma
6 hydoxybutyric acid, its salts, isomers
and salts of
7 isomers, for which an application is
apporved under section
8 505 of the federal Food, Drug and
Cosmetic Act.
9
10 (g) Anabolic
steroids. - Unless specifically excepted
11 or unless listed in another
schedule, any of the following
12 or any isomer, ester, salt or
derivative of the following
13 that acts in the same manner on the
human body:
14
15 (xxvi) Formebulone (formebolone);
16
17 (xxvii) Methenolone;
18
19 (xxviii) Any salt, ester or isomer of a drug or
20 substance
described or listed in this paragraph, if that
21 salt, ester or isomer promotes muscle growth, except the
22 term does not include an anabolic steroid which is
23 expressly intended for administration through implants to
24 cattle or other nonhuman species and which has been
Page 3
1 approved by the United States secretary of health and
2 humans services for such
administration. If any person
3 prescribes, dispenses or distributes
such steroid for human
4 use, the person shall be considered to
have prescribed,
5 dispensed or distributed an anabolic
steroid within the
6 meaning of this paragraph.
7
8 (h) Hallucinogenic substances:
9
10 (i) Dronabinol (synthetic) in sesame oil and
11 encapsulated
in a soft gelatin capsule in a United States
12 Food and Drug Administration approved drug product; some
13 other names for dronobinol include (6aR-trans)-6a,7,8,10a-
14 tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-
15 1-ol, or (-)-delta-9-(trans)-tetrahydrocannabinol.
16
17 35-7-1020. Substances included in Schedule IV.
18
19 (c) Depressants.-Unless
specifically excepted or
20 unless listed in another schedule,
any material, compound,
21 mixture or preparation which
contains any quantity of the
22 following substances, including its
salts, isomers and
23 salts of isomers whenever the
existence of such salts,
Page 4
1 isomers
and salts of isomers is possible within the
2
specific chemical designation:
3
4 (xlix) Zaleplon.
5
6 (e) Stimulants.-Unless
specifically excepted or
7
unless listed in another schedule, any material, compound,
8
mixture or preparation which contains any quantity of the
9
following substances having a stimulant effect on the
10 central nervous system, including
its salts, isomers and
11 salts of isomers:
12
13 (xi) Sibutramine;
14
15 (xii) Modafinil.
16
17 (f) Other substances.-Unless
specifically excepted
18 or unless listed in another
schedule, any material,
19 compound, mixture or preparation
which contains any
20 quantity of the following
substances, including its salts:
21
22 (ii) Butorphanol (including its optical
23 isomers).
24
Page 5
1 Section 2. W.S. 35-7-1016(g)(i) is repealed.
2
3 Section 3. This act is effective July 1, 2001.
4
5 (END)
Page 6